Norges Bank’s Urovant Sciences Ltd. UROV Stock Holding History

Norges Bank’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-125,000	Closed	-$1.5M	–	2142
2018 Q3	$1.5M	Buy	+125,000	New	+$1.48M	﹤0.01%	2058

Other funds holding UROV

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Norges Bank's UROV Position: Q4 2018 in Review

Norges Bank sold out of Urovant Sciences Ltd. (UROV) in Q4 2018, closing a stake of 125,000 shares — an estimated $1.5M sold.

Norges Bank first reported a position in UROV in Q3 2018 and held it in 1 quarter. The position peaked at $1.5M in Q3 2018. 26 funds tracked by Wall St. Rank hold UROV as of Q4 2018.

Norges Bank reported no remaining Urovant Sciences Ltd. position as of Q4 2018 after selling out during the quarter.
Norges Bank sold 125,000 Urovant Sciences Ltd. shares in Q4 2018, an estimated $1.5M.
Norges Bank first reported a position in Urovant Sciences Ltd. in Q3 2018 and held it in 1 quarter.
Norges Bank's Urovant Sciences Ltd. position peaked at $1.5M in Q3 2018.
26 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q4 2018.

Based on Norges Bank's 13F filing for Q4 2018, filed 8 Feb 2019.